nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—POR—Doxorubicin—lung cancer	0.218	0.364	CbGbCtD
Nilutamide—CYP2C19—Gefitinib—lung cancer	0.0607	0.101	CbGbCtD
Nilutamide—CYP2C19—Teniposide—lung cancer	0.0589	0.0982	CbGbCtD
Nilutamide—CYP2C9—Gefitinib—lung cancer	0.0505	0.0842	CbGbCtD
Nilutamide—CYP2C9—Teniposide—lung cancer	0.049	0.0816	CbGbCtD
Nilutamide—CYP2C8—Erlotinib—lung cancer	0.0428	0.0714	CbGbCtD
Nilutamide—CYP2C8—Paclitaxel—lung cancer	0.0392	0.0653	CbGbCtD
Nilutamide—CYP2C8—Etoposide—lung cancer	0.031	0.0516	CbGbCtD
Nilutamide—CYP2C9—Paclitaxel—lung cancer	0.0273	0.0456	CbGbCtD
Nilutamide—CYP2C9—Cisplatin—lung cancer	0.022	0.0366	CbGbCtD
Nilutamide—Flutamide—AHR—lung cancer	0.0049	0.618	CrCbGaD
Nilutamide—Flutamide—CYP1A1—lung cancer	0.00152	0.192	CrCbGaD
Nilutamide—Enzalutamide—ALB—lung cancer	0.000774	0.0976	CrCbGaD
Nilutamide—Enzalutamide—ABCB1—lung cancer	0.000739	0.0931	CrCbGaD
Nilutamide—POR—respiratory system—lung cancer	0.000445	0.125	CbGeAlD
Nilutamide—POR—bronchus—lung cancer	0.000366	0.103	CbGeAlD
Nilutamide—POR—trachea—lung cancer	0.000329	0.0923	CbGeAlD
Nilutamide—CYP2C8—mammary gland—lung cancer	0.000319	0.0895	CbGeAlD
Nilutamide—POR—cardiac atrium—lung cancer	0.000309	0.0867	CbGeAlD
Nilutamide—CYP2C9—mammary gland—lung cancer	0.000283	0.0795	CbGeAlD
Nilutamide—POR—bone marrow—lung cancer	0.000261	0.0732	CbGeAlD
Nilutamide—Dyspepsia—Irinotecan—lung cancer	0.000237	0.000853	CcSEcCtD
Nilutamide—Hypertension—Etoposide—lung cancer	0.000237	0.000853	CcSEcCtD
Nilutamide—Headache—Erlotinib—lung cancer	0.000237	0.000852	CcSEcCtD
Nilutamide—Loss of consciousness—Paclitaxel—lung cancer	0.000237	0.000851	CcSEcCtD
Nilutamide—Gastrointestinal haemorrhage—Doxorubicin—lung cancer	0.000236	0.000851	CcSEcCtD
Nilutamide—Hyperhidrosis—Cisplatin—lung cancer	0.000236	0.000851	CcSEcCtD
Nilutamide—POR—lung—lung cancer	0.000236	0.0663	CbGeAlD
Nilutamide—Paraesthesia—Gemcitabine—lung cancer	0.000236	0.000848	CcSEcCtD
Nilutamide—Cough—Paclitaxel—lung cancer	0.000235	0.000845	CcSEcCtD
Nilutamide—Asthenia—Vinorelbine—lung cancer	0.000234	0.000843	CcSEcCtD
Nilutamide—Decreased appetite—Irinotecan—lung cancer	0.000234	0.000843	CcSEcCtD
Nilutamide—Dyspnoea—Gemcitabine—lung cancer	0.000234	0.000842	CcSEcCtD
Nilutamide—Chest pain—Etoposide—lung cancer	0.000234	0.000841	CcSEcCtD
Nilutamide—Nausea—Vinblastine—lung cancer	0.000233	0.00084	CcSEcCtD
Nilutamide—Anorexia—Cisplatin—lung cancer	0.000233	0.000839	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Irinotecan—lung cancer	0.000233	0.000837	CcSEcCtD
Nilutamide—Hypertension—Paclitaxel—lung cancer	0.000232	0.000836	CcSEcCtD
Nilutamide—Alopecia—Docetaxel—lung cancer	0.000232	0.000833	CcSEcCtD
Nilutamide—Pruritus—Vinorelbine—lung cancer	0.000231	0.000832	CcSEcCtD
Nilutamide—Discomfort—Etoposide—lung cancer	0.000231	0.000831	CcSEcCtD
Nilutamide—Pain—Irinotecan—lung cancer	0.00023	0.000829	CcSEcCtD
Nilutamide—Constipation—Irinotecan—lung cancer	0.00023	0.000829	CcSEcCtD
Nilutamide—Chest pain—Paclitaxel—lung cancer	0.000229	0.000825	CcSEcCtD
Nilutamide—Decreased appetite—Gemcitabine—lung cancer	0.000228	0.000821	CcSEcCtD
Nilutamide—Nausea—Topotecan—lung cancer	0.000227	0.000816	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000226	0.000815	CcSEcCtD
Nilutamide—Discomfort—Paclitaxel—lung cancer	0.000226	0.000815	CcSEcCtD
Nilutamide—Constipation—Gemcitabine—lung cancer	0.000224	0.000807	CcSEcCtD
Nilutamide—Pain—Gemcitabine—lung cancer	0.000224	0.000807	CcSEcCtD
Nilutamide—Nausea—Erlotinib—lung cancer	0.000224	0.000807	CcSEcCtD
Nilutamide—Dry mouth—Paclitaxel—lung cancer	0.000224	0.000807	CcSEcCtD
Nilutamide—Diarrhoea—Vinorelbine—lung cancer	0.000223	0.000804	CcSEcCtD
Nilutamide—Feeling abnormal—Irinotecan—lung cancer	0.000222	0.000799	CcSEcCtD
Nilutamide—Blood creatinine increased—Doxorubicin—lung cancer	0.000221	0.000797	CcSEcCtD
Nilutamide—Back pain—Docetaxel—lung cancer	0.000221	0.000794	CcSEcCtD
Nilutamide—Gastrointestinal pain—Irinotecan—lung cancer	0.00022	0.000793	CcSEcCtD
Nilutamide—Oedema—Paclitaxel—lung cancer	0.00022	0.000791	CcSEcCtD
Nilutamide—AR—epithelium—lung cancer	0.00022	0.0616	CbGeAlD
Nilutamide—Paraesthesia—Cisplatin—lung cancer	0.00022	0.00079	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Methotrexate—lung cancer	0.000219	0.000789	CcSEcCtD
Nilutamide—Dyspnoea—Cisplatin—lung cancer	0.000218	0.000785	CcSEcCtD
Nilutamide—Erectile dysfunction—Methotrexate—lung cancer	0.000217	0.000782	CcSEcCtD
Nilutamide—Dry skin—Doxorubicin—lung cancer	0.000217	0.00078	CcSEcCtD
Nilutamide—Hyperhidrosis—Etoposide—lung cancer	0.000217	0.000779	CcSEcCtD
Nilutamide—AR—bronchus—lung cancer	0.000216	0.0607	CbGeAlD
Nilutamide—Feeling abnormal—Gemcitabine—lung cancer	0.000216	0.000778	CcSEcCtD
Nilutamide—Shock—Paclitaxel—lung cancer	0.000216	0.000778	CcSEcCtD
Nilutamide—Dizziness—Vinorelbine—lung cancer	0.000216	0.000777	CcSEcCtD
Nilutamide—Anorexia—Etoposide—lung cancer	0.000214	0.000769	CcSEcCtD
Nilutamide—Body temperature increased—Irinotecan—lung cancer	0.000213	0.000766	CcSEcCtD
Nilutamide—Abdominal pain—Irinotecan—lung cancer	0.000213	0.000766	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000213	0.000766	CcSEcCtD
Nilutamide—Decreased appetite—Cisplatin—lung cancer	0.000213	0.000765	CcSEcCtD
Nilutamide—Hyperhidrosis—Paclitaxel—lung cancer	0.000212	0.000764	CcSEcCtD
Nilutamide—Pneumonia—Methotrexate—lung cancer	0.000212	0.000762	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Cisplatin—lung cancer	0.000211	0.00076	CcSEcCtD
Nilutamide—Anaemia—Docetaxel—lung cancer	0.000211	0.000759	CcSEcCtD
Nilutamide—Depression—Methotrexate—lung cancer	0.00021	0.000755	CcSEcCtD
Nilutamide—Anorexia—Paclitaxel—lung cancer	0.000209	0.000754	CcSEcCtD
Nilutamide—Pain—Cisplatin—lung cancer	0.000209	0.000753	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000208	0.00075	CcSEcCtD
Nilutamide—Vomiting—Vinorelbine—lung cancer	0.000208	0.000747	CcSEcCtD
Nilutamide—Body temperature increased—Gemcitabine—lung cancer	0.000207	0.000746	CcSEcCtD
Nilutamide—Rash—Vinorelbine—lung cancer	0.000206	0.000741	CcSEcCtD
Nilutamide—Dermatitis—Vinorelbine—lung cancer	0.000206	0.00074	CcSEcCtD
Nilutamide—Headache—Vinorelbine—lung cancer	0.000205	0.000736	CcSEcCtD
Nilutamide—Syncope—Docetaxel—lung cancer	0.000205	0.000736	CcSEcCtD
Nilutamide—Influenza—Doxorubicin—lung cancer	0.000204	0.000735	CcSEcCtD
Nilutamide—Leukopenia—Docetaxel—lung cancer	0.000204	0.000735	CcSEcCtD
Nilutamide—Sweating—Methotrexate—lung cancer	0.000202	0.000726	CcSEcCtD
Nilutamide—Feeling abnormal—Cisplatin—lung cancer	0.000201	0.000725	CcSEcCtD
Nilutamide—Paraesthesia—Etoposide—lung cancer	0.000201	0.000724	CcSEcCtD
Nilutamide—Haematuria—Methotrexate—lung cancer	0.000201	0.000722	CcSEcCtD
Nilutamide—Loss of consciousness—Docetaxel—lung cancer	0.0002	0.000722	CcSEcCtD
Nilutamide—Dyspnoea—Etoposide—lung cancer	0.0002	0.000719	CcSEcCtD
Nilutamide—Cough—Docetaxel—lung cancer	0.000199	0.000716	CcSEcCtD
Nilutamide—Angina pectoris—Doxorubicin—lung cancer	0.000199	0.000716	CcSEcCtD
Nilutamide—Insomnia—Paclitaxel—lung cancer	0.000199	0.000715	CcSEcCtD
Nilutamide—Paraesthesia—Paclitaxel—lung cancer	0.000197	0.00071	CcSEcCtD
Nilutamide—Hypertension—Docetaxel—lung cancer	0.000197	0.000709	CcSEcCtD
Nilutamide—Dyspnoea—Paclitaxel—lung cancer	0.000196	0.000705	CcSEcCtD
Nilutamide—Decreased appetite—Etoposide—lung cancer	0.000195	0.000701	CcSEcCtD
Nilutamide—Chest pain—Docetaxel—lung cancer	0.000194	0.000699	CcSEcCtD
Nilutamide—Nausea—Vinorelbine—lung cancer	0.000194	0.000698	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Etoposide—lung cancer	0.000193	0.000696	CcSEcCtD
Nilutamide—Dyspepsia—Paclitaxel—lung cancer	0.000193	0.000696	CcSEcCtD
Nilutamide—Body temperature increased—Cisplatin—lung cancer	0.000193	0.000696	CcSEcCtD
Nilutamide—Asthenia—Irinotecan—lung cancer	0.000193	0.000696	CcSEcCtD
Nilutamide—Pain—Etoposide—lung cancer	0.000192	0.00069	CcSEcCtD
Nilutamide—Constipation—Etoposide—lung cancer	0.000192	0.00069	CcSEcCtD
Nilutamide—Decreased appetite—Paclitaxel—lung cancer	0.000191	0.000687	CcSEcCtD
Nilutamide—Dry mouth—Docetaxel—lung cancer	0.00019	0.000684	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.00019	0.000683	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00019	0.000683	CcSEcCtD
Nilutamide—Asthenia—Gemcitabine—lung cancer	0.000188	0.000677	CcSEcCtD
Nilutamide—Constipation—Paclitaxel—lung cancer	0.000188	0.000676	CcSEcCtD
Nilutamide—Pain—Paclitaxel—lung cancer	0.000188	0.000676	CcSEcCtD
Nilutamide—Urinary tract disorder—Methotrexate—lung cancer	0.000187	0.000671	CcSEcCtD
Nilutamide—Oedema—Docetaxel—lung cancer	0.000186	0.00067	CcSEcCtD
Nilutamide—Pruritus—Gemcitabine—lung cancer	0.000186	0.000668	CcSEcCtD
Nilutamide—Urethral disorder—Methotrexate—lung cancer	0.000185	0.000666	CcSEcCtD
Nilutamide—Weight decreased—Doxorubicin—lung cancer	0.000185	0.000665	CcSEcCtD
Nilutamide—Feeling abnormal—Etoposide—lung cancer	0.000185	0.000664	CcSEcCtD
Nilutamide—Hyperglycaemia—Doxorubicin—lung cancer	0.000184	0.000663	CcSEcCtD
Nilutamide—Diarrhoea—Irinotecan—lung cancer	0.000184	0.000663	CcSEcCtD
Nilutamide—Pneumonia—Doxorubicin—lung cancer	0.000183	0.00066	CcSEcCtD
Nilutamide—Gastrointestinal pain—Etoposide—lung cancer	0.000183	0.000659	CcSEcCtD
Nilutamide—Shock—Docetaxel—lung cancer	0.000183	0.000659	CcSEcCtD
Nilutamide—AR—cardiac atrium—lung cancer	0.000182	0.0512	CbGeAlD
Nilutamide—Visual impairment—Methotrexate—lung cancer	0.000182	0.000655	CcSEcCtD
Nilutamide—Feeling abnormal—Paclitaxel—lung cancer	0.000181	0.000651	CcSEcCtD
Nilutamide—Gastrointestinal pain—Paclitaxel—lung cancer	0.00018	0.000646	CcSEcCtD
Nilutamide—Diarrhoea—Gemcitabine—lung cancer	0.000179	0.000646	CcSEcCtD
Nilutamide—Dizziness—Irinotecan—lung cancer	0.000178	0.000641	CcSEcCtD
Nilutamide—Anorexia—Docetaxel—lung cancer	0.000177	0.000639	CcSEcCtD
Nilutamide—Abdominal pain—Etoposide—lung cancer	0.000177	0.000637	CcSEcCtD
Nilutamide—Body temperature increased—Etoposide—lung cancer	0.000177	0.000637	CcSEcCtD
Nilutamide—Urinary tract infection—Doxorubicin—lung cancer	0.000177	0.000637	CcSEcCtD
Nilutamide—Asthenia—Cisplatin—lung cancer	0.000175	0.000631	CcSEcCtD
Nilutamide—Sweating—Doxorubicin—lung cancer	0.000175	0.000629	CcSEcCtD
Nilutamide—Haematuria—Doxorubicin—lung cancer	0.000174	0.000625	CcSEcCtD
Nilutamide—Body temperature increased—Paclitaxel—lung cancer	0.000174	0.000625	CcSEcCtD
Nilutamide—Abdominal pain—Paclitaxel—lung cancer	0.000174	0.000625	CcSEcCtD
Nilutamide—Vomiting—Irinotecan—lung cancer	0.000171	0.000616	CcSEcCtD
Nilutamide—Rash—Irinotecan—lung cancer	0.00017	0.000611	CcSEcCtD
Nilutamide—Dermatitis—Irinotecan—lung cancer	0.00017	0.000611	CcSEcCtD
Nilutamide—Headache—Irinotecan—lung cancer	0.000169	0.000607	CcSEcCtD
Nilutamide—Insomnia—Docetaxel—lung cancer	0.000168	0.000606	CcSEcCtD
Nilutamide—Diarrhoea—Cisplatin—lung cancer	0.000167	0.000602	CcSEcCtD
Nilutamide—Paraesthesia—Docetaxel—lung cancer	0.000167	0.000602	CcSEcCtD
Nilutamide—Alopecia—Methotrexate—lung cancer	0.000167	0.000601	CcSEcCtD
Nilutamide—Vomiting—Gemcitabine—lung cancer	0.000167	0.0006	CcSEcCtD
Nilutamide—Dyspnoea—Docetaxel—lung cancer	0.000166	0.000597	CcSEcCtD
Nilutamide—Rash—Gemcitabine—lung cancer	0.000165	0.000595	CcSEcCtD
Nilutamide—Dermatitis—Gemcitabine—lung cancer	0.000165	0.000595	CcSEcCtD
Nilutamide—Headache—Gemcitabine—lung cancer	0.000164	0.000592	CcSEcCtD
Nilutamide—Rhinitis—Doxorubicin—lung cancer	0.000164	0.00059	CcSEcCtD
Nilutamide—Dyspepsia—Docetaxel—lung cancer	0.000164	0.00059	CcSEcCtD
Nilutamide—Hypoaesthesia—Doxorubicin—lung cancer	0.000163	0.000586	CcSEcCtD
Nilutamide—Decreased appetite—Docetaxel—lung cancer	0.000162	0.000583	CcSEcCtD
Nilutamide—Urinary tract disorder—Doxorubicin—lung cancer	0.000162	0.000581	CcSEcCtD
Nilutamide—POR—lymph node—lung cancer	0.000161	0.0453	CbGeAlD
Nilutamide—Oedema peripheral—Doxorubicin—lung cancer	0.000161	0.00058	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000161	0.000579	CcSEcCtD
Nilutamide—Asthenia—Etoposide—lung cancer	0.000161	0.000579	CcSEcCtD
Nilutamide—Urethral disorder—Doxorubicin—lung cancer	0.00016	0.000577	CcSEcCtD
Nilutamide—Nausea—Irinotecan—lung cancer	0.00016	0.000576	CcSEcCtD
Nilutamide—Pain—Docetaxel—lung cancer	0.000159	0.000573	CcSEcCtD
Nilutamide—Constipation—Docetaxel—lung cancer	0.000159	0.000573	CcSEcCtD
Nilutamide—Back pain—Methotrexate—lung cancer	0.000159	0.000572	CcSEcCtD
Nilutamide—Pruritus—Etoposide—lung cancer	0.000158	0.00057	CcSEcCtD
Nilutamide—Visual impairment—Doxorubicin—lung cancer	0.000158	0.000567	CcSEcCtD
Nilutamide—Asthenia—Paclitaxel—lung cancer	0.000158	0.000567	CcSEcCtD
Nilutamide—Nausea—Gemcitabine—lung cancer	0.000156	0.000561	CcSEcCtD
Nilutamide—Vomiting—Cisplatin—lung cancer	0.000155	0.00056	CcSEcCtD
Nilutamide—Pruritus—Paclitaxel—lung cancer	0.000155	0.000559	CcSEcCtD
Nilutamide—Rash—Cisplatin—lung cancer	0.000154	0.000555	CcSEcCtD
Nilutamide—Dermatitis—Cisplatin—lung cancer	0.000154	0.000554	CcSEcCtD
Nilutamide—Feeling abnormal—Docetaxel—lung cancer	0.000153	0.000552	CcSEcCtD
Nilutamide—Diarrhoea—Etoposide—lung cancer	0.000153	0.000552	CcSEcCtD
Nilutamide—Ill-defined disorder—Methotrexate—lung cancer	0.000153	0.000549	CcSEcCtD
Nilutamide—Gastrointestinal pain—Docetaxel—lung cancer	0.000152	0.000548	CcSEcCtD
Nilutamide—Anaemia—Methotrexate—lung cancer	0.000152	0.000547	CcSEcCtD
Nilutamide—Diarrhoea—Paclitaxel—lung cancer	0.00015	0.000541	CcSEcCtD
Nilutamide—Malaise—Methotrexate—lung cancer	0.000148	0.000534	CcSEcCtD
Nilutamide—Dizziness—Etoposide—lung cancer	0.000148	0.000533	CcSEcCtD
Nilutamide—Abdominal pain—Docetaxel—lung cancer	0.000147	0.00053	CcSEcCtD
Nilutamide—Body temperature increased—Docetaxel—lung cancer	0.000147	0.00053	CcSEcCtD
Nilutamide—Leukopenia—Methotrexate—lung cancer	0.000147	0.00053	CcSEcCtD
Nilutamide—Dizziness—Paclitaxel—lung cancer	0.000145	0.000523	CcSEcCtD
Nilutamide—Nausea—Cisplatin—lung cancer	0.000145	0.000523	CcSEcCtD
Nilutamide—Alopecia—Doxorubicin—lung cancer	0.000145	0.00052	CcSEcCtD
Nilutamide—Cough—Methotrexate—lung cancer	0.000143	0.000516	CcSEcCtD
Nilutamide—Vomiting—Etoposide—lung cancer	0.000142	0.000513	CcSEcCtD
Nilutamide—Rash—Etoposide—lung cancer	0.000141	0.000508	CcSEcCtD
Nilutamide—Dermatitis—Etoposide—lung cancer	0.000141	0.000508	CcSEcCtD
Nilutamide—Headache—Etoposide—lung cancer	0.00014	0.000505	CcSEcCtD
Nilutamide—Chest pain—Methotrexate—lung cancer	0.00014	0.000504	CcSEcCtD
Nilutamide—Tension—Doxorubicin—lung cancer	0.00014	0.000503	CcSEcCtD
Nilutamide—Vomiting—Paclitaxel—lung cancer	0.00014	0.000503	CcSEcCtD
Nilutamide—AR—lung—lung cancer	0.00014	0.0392	CbGeAlD
Nilutamide—Rash—Paclitaxel—lung cancer	0.000138	0.000498	CcSEcCtD
Nilutamide—Dermatitis—Paclitaxel—lung cancer	0.000138	0.000498	CcSEcCtD
Nilutamide—Discomfort—Methotrexate—lung cancer	0.000138	0.000498	CcSEcCtD
Nilutamide—Nervousness—Doxorubicin—lung cancer	0.000138	0.000498	CcSEcCtD
Nilutamide—Back pain—Doxorubicin—lung cancer	0.000138	0.000496	CcSEcCtD
Nilutamide—Headache—Paclitaxel—lung cancer	0.000138	0.000495	CcSEcCtD
Nilutamide—Asthenia—Docetaxel—lung cancer	0.000134	0.000481	CcSEcCtD
Nilutamide—Nausea—Etoposide—lung cancer	0.000133	0.000479	CcSEcCtD
Nilutamide—Ill-defined disorder—Doxorubicin—lung cancer	0.000132	0.000475	CcSEcCtD
Nilutamide—Pruritus—Docetaxel—lung cancer	0.000132	0.000474	CcSEcCtD
Nilutamide—Anaemia—Doxorubicin—lung cancer	0.000132	0.000474	CcSEcCtD
Nilutamide—Nausea—Paclitaxel—lung cancer	0.00013	0.00047	CcSEcCtD
Nilutamide—Hyperhidrosis—Methotrexate—lung cancer	0.00013	0.000467	CcSEcCtD
Nilutamide—Malaise—Doxorubicin—lung cancer	0.000128	0.000462	CcSEcCtD
Nilutamide—Anorexia—Methotrexate—lung cancer	0.000128	0.00046	CcSEcCtD
Nilutamide—Syncope—Doxorubicin—lung cancer	0.000128	0.00046	CcSEcCtD
Nilutamide—Leukopenia—Doxorubicin—lung cancer	0.000127	0.000459	CcSEcCtD
Nilutamide—Diarrhoea—Docetaxel—lung cancer	0.000127	0.000458	CcSEcCtD
Nilutamide—Loss of consciousness—Doxorubicin—lung cancer	0.000125	0.00045	CcSEcCtD
Nilutamide—Cough—Doxorubicin—lung cancer	0.000124	0.000447	CcSEcCtD
Nilutamide—Dizziness—Docetaxel—lung cancer	0.000123	0.000443	CcSEcCtD
Nilutamide—Hypertension—Doxorubicin—lung cancer	0.000123	0.000442	CcSEcCtD
Nilutamide—Insomnia—Methotrexate—lung cancer	0.000121	0.000437	CcSEcCtD
Nilutamide—Chest pain—Doxorubicin—lung cancer	0.000121	0.000436	CcSEcCtD
Nilutamide—Paraesthesia—Methotrexate—lung cancer	0.00012	0.000434	CcSEcCtD
Nilutamide—Discomfort—Doxorubicin—lung cancer	0.00012	0.000431	CcSEcCtD
Nilutamide—Dyspnoea—Methotrexate—lung cancer	0.00012	0.000431	CcSEcCtD
Nilutamide—Dry mouth—Doxorubicin—lung cancer	0.000119	0.000427	CcSEcCtD
Nilutamide—Vomiting—Docetaxel—lung cancer	0.000118	0.000426	CcSEcCtD
Nilutamide—Dyspepsia—Methotrexate—lung cancer	0.000118	0.000425	CcSEcCtD
Nilutamide—Rash—Docetaxel—lung cancer	0.000117	0.000423	CcSEcCtD
Nilutamide—Dermatitis—Docetaxel—lung cancer	0.000117	0.000422	CcSEcCtD
Nilutamide—Decreased appetite—Methotrexate—lung cancer	0.000117	0.00042	CcSEcCtD
Nilutamide—Headache—Docetaxel—lung cancer	0.000117	0.00042	CcSEcCtD
Nilutamide—Oedema—Doxorubicin—lung cancer	0.000116	0.000418	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000116	0.000417	CcSEcCtD
Nilutamide—Pain—Methotrexate—lung cancer	0.000115	0.000413	CcSEcCtD
Nilutamide—Shock—Doxorubicin—lung cancer	0.000114	0.000411	CcSEcCtD
Nilutamide—Hyperhidrosis—Doxorubicin—lung cancer	0.000112	0.000404	CcSEcCtD
Nilutamide—Anorexia—Doxorubicin—lung cancer	0.000111	0.000399	CcSEcCtD
Nilutamide—Nausea—Docetaxel—lung cancer	0.000111	0.000398	CcSEcCtD
Nilutamide—Feeling abnormal—Methotrexate—lung cancer	0.000111	0.000398	CcSEcCtD
Nilutamide—Gastrointestinal pain—Methotrexate—lung cancer	0.00011	0.000395	CcSEcCtD
Nilutamide—Abdominal pain—Methotrexate—lung cancer	0.000106	0.000382	CcSEcCtD
Nilutamide—Body temperature increased—Methotrexate—lung cancer	0.000106	0.000382	CcSEcCtD
Nilutamide—Insomnia—Doxorubicin—lung cancer	0.000105	0.000378	CcSEcCtD
Nilutamide—Paraesthesia—Doxorubicin—lung cancer	0.000104	0.000376	CcSEcCtD
Nilutamide—Dyspnoea—Doxorubicin—lung cancer	0.000104	0.000373	CcSEcCtD
Nilutamide—Dyspepsia—Doxorubicin—lung cancer	0.000102	0.000368	CcSEcCtD
Nilutamide—Decreased appetite—Doxorubicin—lung cancer	0.000101	0.000364	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.0001	0.000361	CcSEcCtD
Nilutamide—Constipation—Doxorubicin—lung cancer	9.94e-05	0.000358	CcSEcCtD
Nilutamide—Pain—Doxorubicin—lung cancer	9.94e-05	0.000358	CcSEcCtD
Nilutamide—Asthenia—Methotrexate—lung cancer	9.63e-05	0.000347	CcSEcCtD
Nilutamide—Feeling abnormal—Doxorubicin—lung cancer	9.57e-05	0.000345	CcSEcCtD
Nilutamide—AR—lymph node—lung cancer	9.54e-05	0.0268	CbGeAlD
Nilutamide—Gastrointestinal pain—Doxorubicin—lung cancer	9.5e-05	0.000342	CcSEcCtD
Nilutamide—Pruritus—Methotrexate—lung cancer	9.49e-05	0.000342	CcSEcCtD
Nilutamide—Abdominal pain—Doxorubicin—lung cancer	9.18e-05	0.000331	CcSEcCtD
Nilutamide—Body temperature increased—Doxorubicin—lung cancer	9.18e-05	0.000331	CcSEcCtD
Nilutamide—Diarrhoea—Methotrexate—lung cancer	9.18e-05	0.00033	CcSEcCtD
Nilutamide—Dizziness—Methotrexate—lung cancer	8.87e-05	0.000319	CcSEcCtD
Nilutamide—Vomiting—Methotrexate—lung cancer	8.53e-05	0.000307	CcSEcCtD
Nilutamide—Rash—Methotrexate—lung cancer	8.46e-05	0.000305	CcSEcCtD
Nilutamide—Dermatitis—Methotrexate—lung cancer	8.45e-05	0.000304	CcSEcCtD
Nilutamide—Headache—Methotrexate—lung cancer	8.41e-05	0.000303	CcSEcCtD
Nilutamide—Asthenia—Doxorubicin—lung cancer	8.34e-05	0.0003	CcSEcCtD
Nilutamide—Pruritus—Doxorubicin—lung cancer	8.22e-05	0.000296	CcSEcCtD
Nilutamide—Nausea—Methotrexate—lung cancer	7.97e-05	0.000287	CcSEcCtD
Nilutamide—Diarrhoea—Doxorubicin—lung cancer	7.95e-05	0.000286	CcSEcCtD
Nilutamide—Dizziness—Doxorubicin—lung cancer	7.68e-05	0.000277	CcSEcCtD
Nilutamide—Vomiting—Doxorubicin—lung cancer	7.39e-05	0.000266	CcSEcCtD
Nilutamide—Rash—Doxorubicin—lung cancer	7.33e-05	0.000264	CcSEcCtD
Nilutamide—Dermatitis—Doxorubicin—lung cancer	7.32e-05	0.000263	CcSEcCtD
Nilutamide—Headache—Doxorubicin—lung cancer	7.28e-05	0.000262	CcSEcCtD
Nilutamide—AR—Integrated Breast Cancer Pathway—KRAS—lung cancer	6.99e-05	0.000629	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GSTM1—lung cancer	6.96e-05	0.000627	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTP1—lung cancer	6.91e-05	0.000622	CbGpPWpGaD
Nilutamide—Nausea—Doxorubicin—lung cancer	6.9e-05	0.000248	CcSEcCtD
Nilutamide—CYP2C19—Metapathway biotransformation—GSTM1—lung cancer	6.87e-05	0.000619	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTP1—lung cancer	6.81e-05	0.000614	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.81e-05	0.000613	CbGpPWpGaD
Nilutamide—AR—Gene Expression—RARB—lung cancer	6.79e-05	0.000612	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NPPA—lung cancer	6.62e-05	0.000596	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP1A1—lung cancer	6.6e-05	0.000595	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—CYP1A1—lung cancer	6.51e-05	0.000586	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AZIN2—lung cancer	6.5e-05	0.000586	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—COL4A3BP—lung cancer	6.5e-05	0.000586	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.44e-05	0.00058	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GSTM1—lung cancer	6.35e-05	0.000572	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.26e-05	0.000564	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—GSTM1—lung cancer	6.26e-05	0.000564	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—lung cancer	6.21e-05	0.000559	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.13e-05	0.000552	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.06e-05	0.000546	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP1A1—lung cancer	6.02e-05	0.000542	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—CYP1A1—lung cancer	5.94e-05	0.000535	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.87e-05	0.000529	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AZIN2—lung cancer	5.81e-05	0.000523	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—COL4A3BP—lung cancer	5.81e-05	0.000523	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.79e-05	0.000521	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HSPB1—lung cancer	5.69e-05	0.000513	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—lung cancer	5.54e-05	0.000499	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ATP5H—lung cancer	5.53e-05	0.000498	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—POMC—lung cancer	5.51e-05	0.000497	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	5.41e-05	0.000488	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.32e-05	0.000479	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AZIN2—lung cancer	5.29e-05	0.000477	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—COL4A3BP—lung cancer	5.29e-05	0.000477	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—CREBBP—lung cancer	5.24e-05	0.000472	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—AKT1—lung cancer	5.24e-05	0.000472	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.24e-05	0.000472	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.14e-05	0.000463	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.08e-05	0.000458	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NOTCH3—lung cancer	5.02e-05	0.000452	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ATP5H—lung cancer	4.94e-05	0.000445	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	4.94e-05	0.000445	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PLBD1—lung cancer	4.93e-05	0.000444	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—POMC—lung cancer	4.92e-05	0.000443	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.85e-05	0.000437	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	4.78e-05	0.000431	CbGpPWpGaD
Nilutamide—AR—Gene Expression—JUNB—lung cancer	4.75e-05	0.000428	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.54e-05	0.000409	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HSD17B10—lung cancer	4.51e-05	0.000406	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ATP5H—lung cancer	4.5e-05	0.000405	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—POMC—lung cancer	4.49e-05	0.000404	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PLBD1—lung cancer	4.4e-05	0.000396	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.34e-05	0.000391	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.33e-05	0.00039	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CKB—lung cancer	4.19e-05	0.000378	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	4.14e-05	0.000373	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HSD17B10—lung cancer	4.02e-05	0.000363	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PLBD1—lung cancer	4.01e-05	0.000361	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.95e-05	0.000355	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM2—lung cancer	3.94e-05	0.000355	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CNDP2—lung cancer	3.94e-05	0.000355	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—MTMR3—lung cancer	3.83e-05	0.000345	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CKB—lung cancer	3.74e-05	0.000337	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PGAM1—lung cancer	3.74e-05	0.000337	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HSD17B10—lung cancer	3.67e-05	0.000331	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2A7—lung cancer	3.56e-05	0.000321	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CNDP2—lung cancer	3.52e-05	0.000317	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM2—lung cancer	3.52e-05	0.000317	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—SDC4—lung cancer	3.49e-05	0.000314	CbGpPWpGaD
Nilutamide—AR—Gene Expression—ERCC2—lung cancer	3.45e-05	0.000311	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—MTMR3—lung cancer	3.42e-05	0.000308	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CKB—lung cancer	3.41e-05	0.000307	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PGAM1—lung cancer	3.33e-05	0.0003	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CNDP2—lung cancer	3.21e-05	0.000289	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM2—lung cancer	3.21e-05	0.000289	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2A7—lung cancer	3.18e-05	0.000287	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—RRM1—lung cancer	3.18e-05	0.000286	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTA3—lung cancer	3.18e-05	0.000286	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—MTMR3—lung cancer	3.12e-05	0.000281	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—SDC4—lung cancer	3.11e-05	0.00028	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—MYC—lung cancer	3.11e-05	0.00028	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PGAM1—lung cancer	3.04e-05	0.000274	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—B4GALT5—lung cancer	2.99e-05	0.000269	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTA4—lung cancer	2.91e-05	0.000262	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2A7—lung cancer	2.9e-05	0.000261	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.84e-05	0.000256	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—SDC4—lung cancer	2.84e-05	0.000256	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTA3—lung cancer	2.84e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—RRM1—lung cancer	2.84e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTA2—lung cancer	2.83e-05	0.000255	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTA1—lung cancer	2.73e-05	0.000246	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCC3—lung cancer	2.7e-05	0.000243	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—B4GALT5—lung cancer	2.67e-05	0.00024	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKR1C1—lung cancer	2.62e-05	0.000236	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTA4—lung cancer	2.59e-05	0.000234	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—RRM1—lung cancer	2.59e-05	0.000233	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTA3—lung cancer	2.59e-05	0.000233	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—UGT1A1—lung cancer	2.54e-05	0.000229	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.53e-05	0.000228	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTA2—lung cancer	2.53e-05	0.000228	CbGpPWpGaD
Nilutamide—AR—Gene Expression—CREBBP—lung cancer	2.52e-05	0.000227	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GNG11—lung cancer	2.45e-05	0.000221	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTA1—lung cancer	2.44e-05	0.00022	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.44e-05	0.000219	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—B4GALT5—lung cancer	2.43e-05	0.000219	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCC3—lung cancer	2.41e-05	0.000217	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTA4—lung cancer	2.36e-05	0.000213	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKR1C1—lung cancer	2.33e-05	0.00021	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALDOA—lung cancer	2.33e-05	0.00021	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.31e-05	0.000208	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTA2—lung cancer	2.3e-05	0.000208	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—UGT1A1—lung cancer	2.27e-05	0.000204	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NCOA3—lung cancer	2.26e-05	0.000204	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.22e-05	0.0002	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTA1—lung cancer	2.22e-05	0.0002	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ADCY1—lung cancer	2.2e-05	0.000198	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCG2—lung cancer	2.2e-05	0.000198	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCC3—lung cancer	2.2e-05	0.000198	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GNG11—lung cancer	2.19e-05	0.000197	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.17e-05	0.000196	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—HPGDS—lung cancer	2.16e-05	0.000195	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO2—lung cancer	2.16e-05	0.000195	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PPP2R1B—lung cancer	2.15e-05	0.000193	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKR1C1—lung cancer	2.13e-05	0.000192	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.12e-05	0.000191	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTT1—lung cancer	2.09e-05	0.000189	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALDOA—lung cancer	2.08e-05	0.000187	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GCLC—lung cancer	2.07e-05	0.000186	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2A6—lung cancer	2.07e-05	0.000186	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—UGT1A1—lung cancer	2.07e-05	0.000186	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.06e-05	0.000186	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NCOA3—lung cancer	2.02e-05	0.000182	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GNG11—lung cancer	1.99e-05	0.00018	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.99e-05	0.000179	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.98e-05	0.000179	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ADCY1—lung cancer	1.97e-05	0.000177	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCG2—lung cancer	1.97e-05	0.000177	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ENO1—lung cancer	1.96e-05	0.000177	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.96e-05	0.000176	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.93e-05	0.000174	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO2—lung cancer	1.93e-05	0.000174	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—HPGDS—lung cancer	1.93e-05	0.000174	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.92e-05	0.000173	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALDOA—lung cancer	1.9e-05	0.000171	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.89e-05	0.00017	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTT1—lung cancer	1.87e-05	0.000168	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GCLC—lung cancer	1.85e-05	0.000166	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2A6—lung cancer	1.85e-05	0.000166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NCOA3—lung cancer	1.84e-05	0.000166	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.84e-05	0.000166	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.81e-05	0.000163	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ADCY1—lung cancer	1.79e-05	0.000161	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCG2—lung cancer	1.79e-05	0.000161	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2E1—lung cancer	1.76e-05	0.000159	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—HPGDS—lung cancer	1.76e-05	0.000158	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO2—lung cancer	1.76e-05	0.000158	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ENO1—lung cancer	1.75e-05	0.000158	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.75e-05	0.000157	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.75e-05	0.000157	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—NQO1—lung cancer	1.74e-05	0.000157	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.72e-05	0.000155	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.72e-05	0.000155	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTT1—lung cancer	1.7e-05	0.000154	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.7e-05	0.000154	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.69e-05	0.000152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GCLC—lung cancer	1.68e-05	0.000152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2A6—lung cancer	1.68e-05	0.000152	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.68e-05	0.000151	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ENO1—lung cancer	1.6e-05	0.000144	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.59e-05	0.000143	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2E1—lung cancer	1.57e-05	0.000142	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.57e-05	0.000142	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—STK11—lung cancer	1.57e-05	0.000141	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—NQO1—lung cancer	1.55e-05	0.00014	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MAPK3—lung cancer	1.54e-05	0.000139	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.52e-05	0.000137	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.51e-05	0.000136	CbGpPWpGaD
Nilutamide—AR—Gene Expression—MYC—lung cancer	1.5e-05	0.000135	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.47e-05	0.000133	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTP1—lung cancer	1.45e-05	0.000131	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2E1—lung cancer	1.43e-05	0.000129	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—NQO1—lung cancer	1.42e-05	0.000128	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CAT—lung cancer	1.41e-05	0.000127	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.4e-05	0.000127	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—STK11—lung cancer	1.4e-05	0.000126	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.39e-05	0.000125	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.37e-05	0.000124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ABCB1—lung cancer	1.37e-05	0.000124	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—TYMS—lung cancer	1.35e-05	0.000122	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GSTM1—lung cancer	1.33e-05	0.00012	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.31e-05	0.000118	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTP1—lung cancer	1.3e-05	0.000117	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—STK11—lung cancer	1.28e-05	0.000115	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP1A1—lung cancer	1.26e-05	0.000114	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CAT—lung cancer	1.26e-05	0.000114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ERCC2—lung cancer	1.25e-05	0.000113	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.25e-05	0.000113	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ABCB1—lung cancer	1.23e-05	0.00011	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—TYMS—lung cancer	1.2e-05	0.000109	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.2e-05	0.000108	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GSTM1—lung cancer	1.19e-05	0.000107	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTP1—lung cancer	1.18e-05	0.000106	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CAT—lung cancer	1.15e-05	0.000104	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.14e-05	0.000103	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP1A1—lung cancer	1.13e-05	0.000102	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ERCC2—lung cancer	1.12e-05	0.000101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ABCB1—lung cancer	1.12e-05	0.000101	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—TYMS—lung cancer	1.1e-05	9.89e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GSTM1—lung cancer	1.09e-05	9.78e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—APOA1—lung cancer	1.08e-05	9.77e-05	CbGpPWpGaD
Nilutamide—AR—Gene Expression—AKT1—lung cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.04e-05	9.36e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP1A1—lung cancer	1.03e-05	9.27e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ERCC2—lung cancer	1.02e-05	9.2e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CG—lung cancer	9.91e-06	8.92e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—APOA1—lung cancer	9.68e-06	8.72e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—POMC—lung cancer	9.43e-06	8.49e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	9.27e-06	8.35e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CREBBP—lung cancer	9.18e-06	8.27e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CG—lung cancer	8.84e-06	7.96e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—APOA1—lung cancer	8.83e-06	7.95e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CD—lung cancer	8.71e-06	7.84e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—lung cancer	8.6e-06	7.74e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	8.46e-06	7.62e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—POMC—lung cancer	8.42e-06	7.58e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CREBBP—lung cancer	8.2e-06	7.38e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CG—lung cancer	8.06e-06	7.26e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CD—lung cancer	7.77e-06	7e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—POMC—lung cancer	7.67e-06	6.91e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—lung cancer	7.67e-06	6.91e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CB—lung cancer	7.59e-06	6.84e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTGS2—lung cancer	7.52e-06	6.77e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CREBBP—lung cancer	7.47e-06	6.73e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CD—lung cancer	7.09e-06	6.38e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—lung cancer	7e-06	6.3e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CB—lung cancer	6.77e-06	6.1e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTGS2—lung cancer	6.71e-06	6.05e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—lung cancer	6.56e-06	5.91e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—EP300—lung cancer	6.25e-06	5.63e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CB—lung cancer	6.18e-06	5.56e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTGS2—lung cancer	6.12e-06	5.51e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—lung cancer	5.85e-06	5.27e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—EP300—lung cancer	5.58e-06	5.03e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—lung cancer	5.34e-06	4.81e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—EP300—lung cancer	5.09e-06	4.59e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PIK3CA—lung cancer	4.63e-06	4.17e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PIK3CA—lung cancer	4.13e-06	3.72e-05	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKT1—lung cancer	3.78e-06	3.4e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PIK3CA—lung cancer	3.77e-06	3.39e-05	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKT1—lung cancer	3.37e-06	3.04e-05	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKT1—lung cancer	3.08e-06	2.77e-05	CbGpPWpGaD
